Micelle-Coated, Hierarchically Structured Nanofibers with Dual-Release Capability for Accelerated Wound Healing and Infection Control.
Victoria AlbrightMeng XuAnbazhagan PalanisamyJun ChengMary StackBeilu ZhangArul JayaramanSvetlana A SukhishviliHongjun WangPublished in: Advanced healthcare materials (2018)
Tailoring nanofibrous matrices-a material with much promise for wound healing applications-to simultaneously mitigate bacterial colonization and stimulate wound closure of infected wounds is highly desirable. To that end, a dual-releasing, multiscale system of biodegradable electrospun nanofibers coated with biocompatible micellar nanocarriers is reported. For wound healing, transforming growth factor-β1 is incorporated into polycaprolactone/collagen (PCL/Coll) nanofibers via electrospinning and the myofibroblastic differentiation of human dermal fibroblasts is locally stimulated. To prevent infection, biocompatible nanocarriers of polypeptide-based block copolymer micelles are deposited onto the surfaces of PCL/Coll nanofibers using tannic acid as a binding partner. Micelle-modified fibrous scaffolds are favorable for wound healing, not only supporting the attachment and spreading of fibroblasts comparable to those on noncoated nanofibers, but also significantly enhancing fibroblast migration. Micellar coatings can be loaded with gentamicin or clindamycin and exhibit antibacterial activity as measured by Petrifilm and zone of inhibition assays as well as time-dependent reduction of cellular counts of Staphylococcus aureus cultures. Moreover, delivery time of antibiotic dosage is tunable through the application of a novel modular approach. Altogether, this system holds great promise as an infection-mitigating, cell-stimulating, biodegradable skin graft for wound management and tissue engineering.
Keyphrases
- wound healing
- tissue engineering
- drug delivery
- drug release
- transforming growth factor
- cancer therapy
- staphylococcus aureus
- epithelial mesenchymal transition
- endothelial cells
- stem cells
- human immunodeficiency virus
- pseudomonas aeruginosa
- induced pluripotent stem cells
- extracellular matrix
- dna binding
- soft tissue
- hiv testing
- antiretroviral therapy
- quantum dots
- pluripotent stem cells